Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF3 antisense RNA 1 (ARHGEF3-AS1) is a human long non-coding RNA (lncRNA) gene transcribed from the opposite strand of the ARHGEF3 locus[1][2][6]. It does not code for a protein but may have regulatory effects at the RNA level. Its exact biological function, involvement in disease, role as a biomarker, and any involvement in drug interaction or therapeutic development are currently uncharacterized in the literature and scientific databases[1][2][6]. There is no evidence that ARHGEF3-AS1 itself acts as a therapeutic target, such as a receptor, enzyme, transporter, or classical drug target[1][2][6]. This distinguishes it from the protein-coding gene ARHGEF3, which is a guanine nucleotide exchange factor involved in cell signaling[4][5][7]. The ARHGEF3-AS1 transcript is typically used as a molecular marker for gene regulation studies rather than a direct target for therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGEF3 antisense RNA 1 (ARHGEF3-AS1).